🌸 Big news for those experiencing menopause! A new drug, Veoza, is expected to be available in Ireland by April, offering a fresh approach to managing hot flushes.
What is Veoza?
EMA Approved: Recently got the green light from the European Medicines Agency.
Targeting Hot Flushes: Promises effective relief, especially for those who can't use HRT.
Why It Matters
Hope for Breast Cancer Patients: An alternative for those unable to use Hormone Replacement Therapy (HRT).
Effective and Innovative: Works by regulating core temperature at a brain level.
The Expert's View
Dr. Deirdre Lundy from the National Maternity Hospital's Menopause Clinic is hopeful about Veoza's impact on quality of life, especially for women facing severe symptoms like chronic sleep deprivation.
Availability and Costs
Coming Soon: Expected by March or April.
A Note on Pricing: Might not be covered under the drugs payment scheme initially, indicating a higher cost.
Limitations and Benefits
Not a Cure-All: Doesn't target mood or brain fog like HRT.
Improving Sleep: Can lead to better sleep, indirectly improving mood and cognitive clarity.
HPRA's Role
Final Approvals in Progress: The Health Products Regulatory Authority is working on the final authorizations.
Clinical Trials and Efficacy
Promising Results: Significant reduction in hot flushes compared to placebo.
Side Effects: Includes issues like diarrhoea and difficulty sleeping, but benefits outweigh risks.
In Conclusion
Veoza offers a new horizon for menopause management in Ireland, particularly for those who need an alternative to HRT. Keep an eye out for its arrival and consult with healthcare professionals for personalized advice.